04-Nov-2026 20:47:18

SHUKRA PHARMA Q2 FY27 ; NET PROFIT UP 435% AT ₹13 CR (YOY), DOWN 2% (QOQ)

REVENUE UP 652% AT ₹44 CR (YOY), UP 88% (QOQ) EBITDA UP 4554% AT ₹19 CR (YOY), DOWN 2% (QOQ) MARGINS AT 42.3% VS -7.1% (YOY), 81.4% (QOQ)

SHUKRA PHARMACEUTICALS L